loading
전일 마감가:
$26.67
열려 있는:
$25.77
하루 거래량:
2.14M
Relative Volume:
1.32
시가총액:
$196.33M
수익:
-
순이익/손실:
$-121.02M
주가수익비율:
-1.7913
EPS:
-11.26
순현금흐름:
$-114.09M
1주 성능:
-12.42%
1개월 성능:
+146.58%
6개월 성능:
+38.15%
1년 성능:
-96.61%
1일 변동 폭
Value
$19.42
$25.77
1주일 범위
Value
$19.42
$37.83
52주 변동 폭
Value
$7.31
$672.00

토닉스 파마슈티컬스 홀딩 Stock (TNXP) Company Profile

Name
명칭
Tonix Pharmaceuticals Holding Corp
Name
전화
212-980-9155
Name
주소
26 MAIN STREET, SUITE 101, CHATHAM, NY
Name
직원
0
Name
트위터
@TONIXPharma
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
TNXP's Discussions on Twitter

TNXP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TNXP
Tonix Pharmaceuticals Holding Corp
20.17 196.33M 0 -121.02M -114.09M -11.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

토닉스 파마슈티컬스 홀딩 Stock (TNXP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-04-18 개시 Noble Capital Markets Outperform
2019-04-18 업그레이드 ROTH Capital Neutral → Buy
2017-08-18 업그레이드 ROTH Capital Neutral → Buy
2016-09-07 다운그레이드 ROTH Capital Buy → Neutral
2016-02-17 재확인 Oppenheimer Outperform
2015-11-04 개시 Cantor Fitzgerald Buy
2015-06-12 개시 Oppenheimer Outperform
2015-02-17 재확인 ROTH Capital Buy
2014-09-29 재확인 ROTH Capital Buy
모두보기

토닉스 파마슈티컬스 홀딩 주식(TNXP)의 최신 뉴스

pulisher
Mar 27, 2025

(TNXP) Long Term Investment Analysis - Stock Traders Daily

Mar 27, 2025
pulisher
Mar 27, 2025

Tonix Pharmaceuticals Announces Presentation at the - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Fast-Tracked Fibromyalgia Treatment: Tonix Showcases Breakthrough Pain Drug Data Before FDA Decision - StockTitan

Mar 27, 2025
pulisher
Mar 27, 2025

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting - Yahoo Finance

Mar 27, 2025
pulisher
Mar 26, 2025

2 Stocks Riding the Biotech Surge With Major Catalysts Ahead - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 Years - Seeking Alpha

Mar 26, 2025
pulisher
Mar 25, 2025

Noble Capital maintains Outperform on Tonix Pharma, $70 target By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Noble Capital maintains Outperform on Tonix Pharma, $70 target - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Tonix Pharmaceuticals: FDA AdCom News Positive, But Making Bull Case Is Problematic (TNXP) - Seeking Alpha

Mar 25, 2025
pulisher
Mar 25, 2025

Pharma Frenzy: Volatility Ignites Biotech Sector - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga

Mar 25, 2025
pulisher
Mar 24, 2025

Tonix advances fibromyalgia drug, eyes Q4 2025 launch By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment; Shares Up - Marketscreener.com

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix advances fibromyalgia drug, eyes Q4 2025 launch - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment - Marketscreener.com

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals stock soars on FDA update By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals stock soars on FDA update - Investing.com

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharma’s TNX-102 SL Advances in FDA Process - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals Announces that FDA Will Not Require - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

First New Fibromyalgia Treatment in 15 Years Advances: FDA Expedites TNX-102 SL Review - StockTitan

Mar 24, 2025
pulisher
Mar 22, 2025

Tonix Pharmaceuticals Stock Dives After Q4 Earnings Miss, But Retail’s Feeling Bullish - MSN

Mar 22, 2025
pulisher
Mar 21, 2025

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread - BioSpace

Mar 21, 2025
pulisher
Mar 20, 2025

New Single-Dose Mpox Vaccine Outperforms Existing Options as Cases Surge Worldwide - StockTitan

Mar 20, 2025
pulisher
Mar 19, 2025

Tonix Pharma stock drops after Q4 revenue miss (TNXP:NASDAQ) - Seeking Alpha

Mar 19, 2025
pulisher
Mar 19, 2025

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Tonix Pharmaceuticals Reports 2024 Financial Results and Pipeline Progress - TipRanks

Mar 19, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals stock tumbles on earnings miss - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharma earnings missed by $5.86, revenue fell short of estimates - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals stock tumbles on earnings miss By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals Holding Corp. SEC 10-K Report - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals 8-K Filing Analysis - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals Holding Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Secures Path to First New Fibromyalgia Drug in 15 Years with $98.8M War Chest - StockTitan

Mar 18, 2025
pulisher
Mar 17, 2025

Learn to Evaluate (TNXP) using the Charts - Stock Traders Daily

Mar 17, 2025
pulisher
Mar 16, 2025

* Tonix pharmaceuticals announces 1-for-10 reverse stock split - Reuters

Mar 16, 2025
pulisher
Mar 14, 2025

Tonix Pharmaceuticals secures MCDC grant to advance next-gen Mpox & Smallpox vaccine development - Proactive Investors USA

Mar 14, 2025
pulisher
Mar 14, 2025

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing - The Manila Times

Mar 14, 2025
pulisher
Mar 13, 2025

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025 - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Major FDA Decision Looms: Tonix's Revolutionary Fibromyalgia Treatment Could End 15-Year Innovation Drought - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target - BioSpace

Mar 12, 2025
pulisher
Mar 12, 2025

Tonix's TNX-1500 Shows Promise in Preventing Organ Transplant Re - NEWS CHANNEL NEBRASKA

Mar 12, 2025
pulisher
Mar 12, 2025

Clinical Trial Success: Tonix's New Drug Could Revolutionize $5.5B Transplant Market - StockTitan

Mar 12, 2025
pulisher
Mar 11, 2025

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week - MSN

Mar 11, 2025
pulisher
Mar 11, 2025

Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Tonix Pharmaceuticals to Present at Zacks SCR Life Sciences Virtual Investor Forum - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Tonix Unveils FDA Timeline and Pipeline Progress: Live Q&A with CEO March 13 - StockTitan

Mar 11, 2025
pulisher
Mar 10, 2025

Tonix Pharma Secures Grant for TNX-801 Vaccine Development - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Tonix Pharmaceuticals receives MCDC grant for devloping its single-dose Mpox and Smallpox vaccine - Marketscreener.com

Mar 10, 2025

토닉스 파마슈티컬스 홀딩 (TNXP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
자본화:     |  볼륨(24시간):